Irbediur (Hydrochlorothiazide, Irbesartan)

Irbediur is used to manage conditions within the cardiovascular and renal disease spectrum where blood‑pressure reduction is required.

• Hypertension: lowers systolic and diastolic pressure, helping to prevent stroke and heart attack.
• Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.
• Left ventricular hypertrophy: reduces cardiac workload by controlling elevated blood pressure.

• Irbesartan selectively blocks AT1 receptors, preventing angiotensin II from causing vasoconstriction and aldosterone release. Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, promoting diuresis and decreasing plasma volume. The combined actions result in reduced peripheral resistance and lowered blood volume, producing an overall antihypertensive effect.

Common Side Effects

• Dizziness: feeling light‑headed, especially after standing.
• Headache: mild to moderate pain in the head region.
• Fatigue: general tiredness or lack of energy.
• Increased urination: more frequent need to void.
• Electrolyte imbalance: changes in potassium or sodium levels.
• Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

• Severe dehydration: marked fluid loss requiring medical attention.
• Hyperkalemia: dangerously high potassium that can affect heart rhythm.
• Acute kidney injury: sudden decline in renal function.
• Angioedema: swelling of face, lips, tongue, or throat.
• Severe allergic reaction: rash, itching, or anaphylaxis.
• Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating therapy, consider the following precautions.

• Blood pressure monitoring: ensure target levels are achieved without excessive drop.
• Electrolyte assessment: regularly check potassium and sodium concentrations.
• Renal function evaluation: assess creatinine and eGFR, especially in patients with pre‑existing kidney disease.
• Pregnancy avoidance: drug is contraindicated in pregnancy due to fetal risk.
• NSAID use: avoid concurrent non‑steroidal anti‑inflammatory drugs that may impair renal function.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Irbediur may interact with several medicines; awareness of these interactions helps maintain safety.

Major Interactions (Avoid)

• Potassium‑sparing diuretics or supplements: risk of hyperkalemia.
• Lithium: increased lithium levels leading to toxicity.
• ACE inhibitors or other ARBs: additive effects on blood pressure and renal function.

Moderate Interactions (Monitor Closely)

• NSAIDs: may reduce antihypertensive efficacy and affect kidney function.
• Antidiabetic agents: potential for enhanced hypoglycaemia.
• CYP2C9 inhibitors (e.g., fluconazole): may raise irbesartan concentrations.